Summary This article explores the advancements in screening and managing screen-detected type 1 diabetes, especially in young people. It discusses the benefits of early detection, including timely intervention and improved management. Furthermore, the article emphasizes […]
Summary This article explores the groundbreaking research project, SGLT2 HYPE, investigating the potential of dapagliflozin, a type 2 diabetes treatment, to reduce heart problems. The study aims to determine if dapagliflozin can prevent serious cardiovascular […]
Summary This article explores the groundbreaking research linking high muscle strength to a significantly reduced risk of type 2 diabetes. It delves into the science behind this correlation, emphasizing the metabolic benefits of muscle and […]
Summary Senseonics’ Eversense 365 CGM, the first FDA-cleared one-year continuous glucose monitor, offers significant advancements in diabetes management. Its partnership with Sequel integrates the CGM into an automated insulin dosing system, improving patient care. This […]
Summary A new study reveals that semaglutide, the active ingredient in Ozempic and Wegovy, may reverse signs of liver disease in two-thirds of patients. The research, published in the New England Journal of Medicine, shows […]
Summary This article explores the risks of diabetes during pregnancy for both mother and baby. It details potential complications like preterm birth, birth defects, and macrosomia. The article also highlights the importance of diabetes management […]
Summary Nearly 40% of type 2 diabetes patients stop their medication within the first year. This non-adherence raises concerns about long-term health outcomes and healthcare costs. Doctors must adopt personalized treatment strategies and address individual […]
Summary This article discusses a recent study published in Diabetes Care which found that high blood sugar in adolescence can triple the risk of premature heart damage, impacting young women more severely than young men. […]
Summary Eli Lilly’s GLP-1 pill, Rybelsus (semaglutide), offers a groundbreaking oral treatment for type 2 diabetes, effectively controlling blood sugar levels. It also demonstrates significant potential for weight loss, making it a promising advancement in […]
Summary GLP-1 agonists, popular weight-loss drugs, may also offer protection against dementia. Studies suggest these medications could reduce the risk of Alzheimer’s and other cognitive impairments. This adds to the growing list of potential benefits […]
© 2025 Newsguru LTD. All rights reserved.